CorMedix (CRMD)

• Market cap: $649M
• 1 day: 3.63%
• 5 days: 4.55%
• 1 month: 5.75%
• 3 months: 12.52%
• 6 months: -14.3%
• Year to date: -31.99%
• 1 year: -34%
• 5 years: 15.66%
• 10 years: -45.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 191